The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cellsKrzysztof Bielawski1, Robert Czarnomysy1, Agnieszka Gornowicz2, Karolina Lendzion2, and Michal Tomczyk3
|
The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cellsAnna Bielawska1, Karolina Lendzion1, Agnieszka Gornowicz1, Krzysztof Bielawski2, and Michal Tomczyk3
|
The anti-proliferative and anti-inflammatory effect of a novel
4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cellsRoman Lesyk1,2, Agnieszka Gornowicz 3, Magdalena Podolak3, Rostyslav Dudchak4, Krzysztof Bielawski4, and Anna Bielawska3
|
Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironmentLajos Raduly, Andreea Nutu, Cristina Ciocan, Oana Zanoaga, Cecilia Bica, Laura Pop, Cornelia Braicu, and Ioana Berindan-Neagoe
|
The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study Andreea Nutu1, Lajos Raduly1, Liviuta Budisan 1, Cristina Ciocan1, Antonia Harangus1,2, Cecilia Bica1, Sergiu Chira1, Cornelia Braicu1, and Ioana Berindan-Neagoe1
|
Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancerPaul Chiroi1, Ovidiu Pop2, Ecaterina Isacescu1, Cristina Ciocan1, Cecilia Bica1, Cornelia Braicu1, and Ioana Berindan-Neagoe1
|
Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotypeGiorgia Colombo1, Cristina Travelli2, Sabina Sangaletti3, and Armando Genazzani1
|
TYK2 inhibition causes not only apoptosis but also a marked anti-tumor
immune response in Anaplastic Large Cell LymphomaCatello Giordano1, Judith Leitner2, Peter Steinberger2, Anna Chen3, Dietmar Herndler-Brandstetter3, Nicole Prutsch4, Lukas Kenner1,5, and Olaf Merkel1
|
Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugsCatello Giordano1, Nicole Prutsch2, Huang-Chang Liang3, Anna Aplenc1, Lukas Kenner1, Thomas Look2, Mohamed Touaibia5, and Olaf Merkel1
|
eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotypeFederica Balestrero, Marianna Moro, Fabrizio Condorelli, Armando Genazzani, and Ambra Grolla
|
Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progressionMarianna Moro1, Valerio Ciccone2, Federica Balestrero1, Armando Genazzani1, and Ambra Grolla1
|
Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma modelDaniel Harari and Gideon Schreiber
|